In Alzheimer’s disease, GPCR is involved as a modulator of amyloid-beta generation through the modulation of α-, β-, and γ-secretases in the proteolysis of amyloid precursor protein (APP) [95]. This evidence concerns the gene APP and Alzheimer disease.